drugset / Trial / NCT00596271
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
RandomizedParallel-groupSingle-blindPrevention
Summary
The objective is to investigate the immunogenicity of the Japanese Encephalitis vaccine IC51 (JE-PIV) single and concomitant with HAVRIX® 1440
Timeline
- Start
- 2005-09
- Primary completion
- 2006-07
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Havrix | Vaccine | — | — |
| Comparator | IC51 | Vaccine | 6 ug | Intramuscular |